HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

X Wu Selected Research

16-hydroxypseudojolkinolide B

10/2000[Studies on Euphorbia fischeriana diterpenoide lactones inhibitory effect on human tumor cells in vitro].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


X Wu Research Topics

Disease

100Neoplasms (Cancer)
04/2022 - 01/2000
23Infections
05/2022 - 01/2000
22Lung Neoplasms (Lung Cancer)
04/2022 - 01/2000
18Neoplasm Metastasis (Metastasis)
09/2020 - 10/2000
13Carcinoma (Carcinomatosis)
04/2022 - 01/2000
12Carcinogenesis
01/2017 - 02/2000
11Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2019 - 11/2001
11Inflammation (Inflammations)
11/2017 - 11/2005
9Breast Neoplasms (Breast Cancer)
01/2017 - 02/2000
9Hypertension (High Blood Pressure)
02/2016 - 01/2000
7Cardiovascular Diseases (Cardiovascular Disease)
05/2022 - 03/2000
7Insulin Resistance
02/2020 - 09/2000
7Tuberculosis (Tuberculoses)
11/2017 - 04/2000
7Nasopharyngeal Carcinoma
07/2017 - 12/2001
7Hypoxia (Hypoxemia)
11/2016 - 01/2000
6Hepatocellular Carcinoma (Hepatoma)
04/2022 - 02/2000
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 05/2008
5Stomach Neoplasms (Stomach Cancer)
11/2021 - 02/2014
5Systemic Lupus Erythematosus (Libman-Sacks Disease)
10/2021 - 01/2001
5Adenocarcinoma
05/2021 - 03/2001
5Wounds and Injuries (Trauma)
10/2020 - 11/2012
5Prostatic Neoplasms (Prostate Cancer)
11/2019 - 07/2001
5Obesity
01/2019 - 11/2009
5Ischemia
12/2017 - 01/2000
5Lymphatic Metastasis
01/2017 - 04/2001
5Urinary Bladder Neoplasms (Bladder Cancer)
01/2016 - 01/2004
5Necrosis
11/2014 - 03/2000
5Body Weight (Weight, Body)
12/2013 - 12/2001
5Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
12/2011 - 04/2000
4Fever (Fevers)
01/2022 - 06/2015
4Adenocarcinoma of Lung
01/2022 - 05/2009
4HIV Infections (HIV Infection)
01/2021 - 07/2014
4Type 2 Diabetes Mellitus (MODY)
02/2020 - 11/2008
4Parkinson Disease (Parkinson's Disease)
03/2018 - 12/2006
4Cicatrix (Scar)
01/2018 - 03/2001
4Renal Cell Carcinoma (Grawitz Tumor)
01/2017 - 05/2001
4Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 05/2005
4Osteoporosis
10/2016 - 05/2011
4Rheumatoid Arthritis
04/2016 - 04/2000
4Colitis
01/2016 - 01/2008
4Hypothermia
01/2016 - 04/2001
4Hypersensitivity (Allergy)
07/2014 - 12/2001
4Alzheimer Disease (Alzheimer's Disease)
05/2013 - 04/2000
4Myopia
05/2001 - 06/2000
3Pancreatitis
05/2022 - 01/2000
3Pneumonia (Pneumonitis)
04/2022 - 11/2001
3Communicable Diseases (Infectious Diseases)
01/2022 - 01/2015
3Intracranial Aneurysm (Cerebral Aneurysm)
09/2021 - 11/2015

Drug/Important Bio-Agent (IBA)

46Proteins (Proteins, Gene)FDA Link
04/2022 - 01/2000
15Pharmaceutical PreparationsIBA
08/2020 - 03/2000
13Messenger RNA (mRNA)IBA
04/2022 - 12/2001
12Biomarkers (Surrogate Marker)IBA
11/2018 - 01/2009
11DNA (Deoxyribonucleic Acid)IBA
10/2021 - 01/2000
10CytokinesIBA
02/2021 - 09/2001
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2016 - 10/2000
9MicroRNAs (MicroRNA)IBA
01/2018 - 10/2010
8Biological ProductsIBA
07/2022 - 04/2001
7Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 01/2015
7AutoantibodiesIBA
10/2021 - 04/2000
6Small Interfering RNA (siRNA)IBA
04/2022 - 05/2009
6SaltsIBA
06/2021 - 03/2000
6Complementary DNA (cDNA)IBA
06/2021 - 10/2000
6EnzymesIBA
01/2017 - 02/2000
6Cisplatin (Platino)FDA LinkGeneric
12/2016 - 01/2004
6AntibodiesIBA
12/2016 - 09/2000
6AntigensIBA
02/2014 - 02/2000
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 05/2014
5Interleukin-10 (Interleukin 10)IBA
01/2022 - 10/2010
5Interleukin-6 (Interleukin 6)IBA
02/2021 - 12/2001
5RNA (Ribonucleic Acid)IBA
11/2018 - 01/2000
5Insulin (Novolin)FDA Link
12/2011 - 04/2000
4Therapeutic UsesIBA
04/2022 - 01/2000
4InterleukinsIBA
01/2022 - 02/2000
4Phosphotransferases (Kinase)IBA
01/2022 - 01/2001
4CalciumIBA
08/2021 - 03/2000
4Interleukin-1 (Interleukin 1)IBA
02/2021 - 07/2013
4Indicators and Reagents (Reagents)IBA
12/2019 - 03/2000
4Proliferating Cell Nuclear Antigen (PCNA)IBA
08/2018 - 08/2000
4IronIBA
07/2018 - 03/2008
4VaccinesIBA
06/2018 - 07/2014
4LigandsIBA
03/2018 - 09/2001
4Transcription Factors (Transcription Factor)IBA
01/2018 - 04/2001
4salicylhydroxamic acid (SHAM)IBA
11/2015 - 03/2012
4NF-kappa B (NF-kB)IBA
09/2014 - 03/2007
4Glucose (Dextrose)FDA LinkGeneric
12/2013 - 09/2003
4DNA VaccinesIBA
07/2011 - 04/2000
4Monoamine Oxidase (MAO)IBA
12/2001 - 02/2000
4Saline SolutionIBA
12/2001 - 04/2001
4Bleomycin (Blenoxane)FDA LinkGeneric
08/2000 - 01/2000
3GlucocorticoidsIBA
04/2022 - 11/2009
3InterferonsIBA
01/2022 - 10/2005

Therapy/Procedure

29Therapeutics
08/2021 - 06/2000
16Radiotherapy
11/2021 - 05/2000
9Drug Therapy (Chemotherapy)
05/2021 - 02/2000
6Brachytherapy
03/2021 - 12/2001
5Aftercare (After-Treatment)
04/2022 - 05/2000
4Length of Stay
04/2022 - 04/2020
4Oral Administration
01/2016 - 10/2003
4Excimer Lasers
05/2001 - 06/2000
3Sutures (Suture)
02/2022 - 01/2017